Atlas Trials

DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant

Clinical trial NCT03208127 · TERMINATED

Trial details

NCT number
NCT03208127
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
End Stage Liver DiseaseHepatitis C
Start date
2017-11-21
Primary completion
2021-06-04
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.